# Health Economic Impact of Incomplete Reperfusion Patterns After Endovascular Thrombectomy in Acute Ischemic Stroke

**Authors:** Alexander Stebner, Petra Cimflova, Salome L. Bosshart, Wolfgang G. Kunz, Pervinder Bhogal, Michael Hill, Mayank Goyal, Johanna M. Ospel

PMC · DOI: 10.1007/s00062-025-01524-5 · 2025-08-28

## TL;DR

Incomplete reperfusion after stroke treatment affects outcomes and costs, with complete reperfusion being the most economically beneficial.

## Contribution

This study evaluates the health-economic benefits of improving incomplete reperfusion patterns after endovascular thrombectomy.

## Key findings

- Complete reperfusion (eTICI 2c3) results in lower costs and higher quality-adjusted life-years compared to incomplete patterns.
- EVT-accessible incomplete reperfusion may benefit from additional EVT attempts, while EVT-non-accessible patterns may benefit from pharmacological therapies.

## Abstract

Incomplete reperfusion in endovascular thrombectomy (EVT) impacts patients’ outcomes. Different incomplete reperfusion patterns may benefit from targeted therapeutic strategies, e.g. EVT-accessible incomplete reperfusion patterns could improve by performing additional EVT attempts, while EVT-non-accessible incomplete patterns might benefit from pharmacological therapies. The health-economic implications of these therapies are uncertain. This study aims to assess the potential economic benefits of improving incomplete reperfusion patterns after EVT.

Retrospective Data analysis from the ESCAPE-NA1 trial, which included patients with large vessel occlusion strokes undergoing EVT. Reperfusion patterns were classified as near-/complete (eTICI 2c3), EVT-accessible incomplete (eTICI 2b), or EVT-non-accessible incomplete (eTICI 2b) and we compared multiple attempts to achieve eTICI 2c3 vs. first-pass eTICI 2c3. A Markov-Model was built to compare lifetime costs and quality adjusted life-years (QALY) for each reperfusion pattern over a lifetime horizon, considering both healthcare and societal perspectives.

A total of 1105 of patients were enrolled in the ESCAPE-NA1 trial of which 949 with eTICI 2b, 2c and 3 were further analyized (mean age 70.7 ± 13.6 [SD]; 463 female). Near-Complete reperfusion (eTICI 2c3) was achieved in 506/1105 patients (45.8%). Incomplete reperfusion patterns (eTICI 2b) were found in 450/1105 (40.7%) patients. Angiography imaging could be further investigated in 443/450 (98.4%) cases with 147/443(33.2%) EVT-accessible and 296/443(66.8%) EVT-non-accessible incomplete reperfusion patterns. Compared to EVT-accessible and EVT-non-accssible incomplete reperfusion, achieving complete (eTICI 2c3) reperfusion resulted in lower costs and an additional 1.14/0.45 QALYs, making it the dominant strategy from a health-economic perspective. In the complete reperfusion (eTICI 2c3) group, cumulative lifetime QALYs were similar with 5.25 for single-pass eTICI 2c3 and 5.19 for multi-pass eTICI 2c3.

Improving incomplete reperfusion patterns after EVT has considerable potential health economic benefits, both in the presence and absence of a target occlusion that is amenable to EVT.

The online version of this article (10.1007/s00062-025-01524-5) contains supplementary material, which is available to authorized users.

## Full-text entities

- **Diseases:** large vessel occlusion strokes (MESH:C536223), eTICI 2b (MESH:C536043), Acute Ischemic Stroke (MESH:D000083242)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13009091/full.md

---
Source: https://tomesphere.com/paper/PMC13009091